The role of rs_7927894 FLG gene polymorphism and total IgE in predicting clinical phenotypes of atopic dermatitis in children
DOI:
https://doi.org/10.15574/SP.2021.115.31Keywords:
atopic dermatitis, children, phenotype, filaggrin gene, single-nucleotide polymorphism, total immune globulin EAbstract
Atopic dermatitis (AD) is the most common chronic allergic disease of childhood, the pathogenesis of which is based on endogenous genotype and which manifests by various clinical phenotypes — isolated or combined with other forms of atopy — allergic rhinitis/rhinoconjunctivitis (AR/ARC) and/or bronchial asthma (BA). Currently, one of the most studied genetic markers of AD developmental risk is the single nucleotide polymorphism of the filaggrin gene (SNP FLG), in particular, rs_7927894. The basic AD biomarker is total serum immunoglobulin E (IgE). But, so far, there has been no studies combining the mentioned predictors markers within different clinical AD phenotypes in children.
Purpose — to detect the variants of SNP rs_7927894 of FLG gene and serum total IgE concentrations as personalized predictors panel for different AD clinical phenotypes developmental risk in children.
Materials and methods. There were recruited 2 groups of patients into the study: the main comprised 39 children with phenotypes of AD isolated and combined with AR/ARC and/or BA; the control group comprised 47 children with disorders of digestive system (functional dyspepsia, chronic gastritis, peptic ulcer, functional biliary disorders) without clinical signs of atopy. The threshold level of statistical significance was set as p<0.05.
Results. There were detected the predictor genotype and biomarker for the AD developmental risk as per AD isolated phenotype: 4.11 (95% CI 1.28; 13.18, p<0.05) within C/T SNP rs_7927894 of FLG gene variant and 8.98 (95% CI 2.53, 31.86, p<0.001) for total serum IgE>173 IU/ml. As well, predictor genotype and biomarker for the developmental risk of the AD combined with AR/ARC/BA phenotype were detected: 2.88 (95% 1.07; 8.54, p<0.05) within the C/T SNP rs_7927894 of FLG gene variant and 8.98 (95% CI 2.53; 31.86, p<0.001) for total serum IgE>213 IU/ml. Additionally, the developmental risk for the phenotype of AD combined with AR/ARC/ BA in comparison with AD isolated at a cut-off serum total IgE>1001 IU/ml was detected as 16.00 (95% CI 2.68; 95.44, p<0.01).
Conclusions. The C/T SNP rs_7927894 of FLG gene variant and cut(off serum IgE concentrations are significantly associated with the developmental risk of AD clinical phenotypes in children. Total IgE remains a significant predictor biomarker of AD risk in children aged 3 to 18 years at serum concentrations >173 IU/ml for the AD isolated and at serum concentrations >213 IU/ml for the AD combined with AR/ARC/AD phenotypes. The level of total serum IgE>1001 IU/ml is a
significant predictor biomarker for the developmental risk of AD phenotype combined with AR/ARC/BA in comparison to the AD isolated phenotype in children.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institution. The informed consent of the patient was obtained for conducting the studies.
No conflict of interest was declared by the authors.
References
Amat F, Soria A, Tallon P, Bourgoin Heck M, Lambert N, Deschildre A, Just J. (2018, Aug). New insights into the phenotypes of atopic dermatitis linked with allergies and asthma in children: An overview. Clin Exp Allergy. 48 (8): 919-934. Epub 2018 May 24. https://doi.org/10.1111/cea.13156; PMid:29676818
Badloe FMS, De Vriese S, Coolens K et al. (2020). IgE autoantibodies and autoreactive T cells and their role in children and adults with atopic dermatitis. Clin Transl Allergy. 10 (34). https://doi.org/10.1186/s13601-020-00338-7; PMid:32774842 PMCid:PMC7398196
Belgrave DCM, Simpson A, Buchan IE et al. (2015). Atopic Dermatitis and Respiratory Allergy: What is the Link. Curr Derm Rep. 4: 221-227. https://doi.org/10.1007/s13671-015-0121-6; PMid:26566461 PMCid:PMC4635175
Cabanillas B, Brehler AC, Novak N. (2017, Aug). Atopic dermatitis phenotypes and the need for - personalized medicine. Curr Opin Allergy Clin Immunol. 17 (4): 309-315. https://doi.org/10.1097/ACI.0000000000000376; PMid:28582322 PMCid:PMC5515628
Cepelak I, Dodig S, Pavic I. (2019). Filaggrin and atopic march. Biochem Med (Zagreb). 29 (2): 020501. https://doi.org/10.11613/BM.2019.020501; PMid:31223255 PMCid:PMC6559618
Debinska A, Danielewicz H, Drabik Chamerska A, Kalita D, Boznanski A. (2020). Chromosome 11q13.5 variant as a risk factor for atopic dermatitis in children. Postepy Dermatol Alergol. 37 (1): 103-110. https://doi.org/10.5114/ada.2020.93388; PMid:32467693 PMCid:PMC7247065
Hill DA, Spergel JM. (2018). The atopic march: Critical evidence and clinical relevance. Annals of Allergy, Asthma&Immunology. 120 (2): 131 137. ISSN10811206. https://doi.org/10.1016/j.anai.2017.10.037; PMid:29413336 PMCid:PMC5806141
Johansson SGO. (2016, Jun). The discovery of IgE. J Allergy Clin Immunol. 137 (6): 1671-1673. Epub 2016 Apr 23. https://doi.org/10.1016/j.jaci.2016.04.004; PMid:27264002
Mavroudi A, Karagiannidou A, Xinias I, Cassimos D, Karantaglis N, Farmaki E, Imvrios G, Fotoulaki M, Eboriadou M, Tsanakas J. (2017, Jan Feb). Assessment of IgE-mediated food allergies in children with atopic dermatitis. Allergol Immunopathol (Madr). 45 (1): 77-81. Epub 2016 Oct 4. https://doi.org/10.1016/j.aller.2016.06.006; PMid:27717723
Ng C, Hon KL, Kung JS, Pong NH, Leung TF, Wong CK. (2016). Hyper IgE in Childhood Eczema and Risk of Asthma in Chinese Children. Molecules. 21 (6): 753. Published 2016 Jun 10. https://doi.org/10.3390/molecules21060753; PMid:27294900 PMCid:PMC6274365
Poni'nska JK, Samoli'nski B, Tomaszewska A, Raciborski F, Samel Kowalik P, Walkiewicz A, Lipiec A, Piekarska B, Krzych Falta E, Namyslowski A et al. (2017). Haplotype dependent association of rs7927894 (11q13.5) with atopic dermatitis and chronic allergic rhinitis: A study in ECAP cohort. PLoS ONE. 12: e0183922. https://doi.org/10.1371/journal.pone.0183922; PMid:28886043 PMCid:PMC5590850
Rosi'ska Wieckowicz A, Czarnecka Operacz M, Adamski Z. (2016). Selected immunological parameters in clinical evaluation of patients with atopic dermatitis. Advances in Dermatology and Allergology/Postepy Dermatologii i Alergologii. 33 (3): 211-218. https://doi.org/10.5114/ada.2016.60614; PMid:27512357 PMCid:PMC4969417
Suarez Farinas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman Strong C et al. (2013). Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared ith extrinsic atopic dermatitis. J Allergy Clin Immunol. 132: 361-370. Epub 2013 Jun 15. https://doi.org/10.1016/j.jaci.2013.04.046; PMid:23777851 PMCid:PMC3991240
Vaneckova J, Bukac J. (2016). The severity of atopic dermatitis and the relation to the level of total IgE, onset of atopic dermatitis and family history about atopy, Food and Agricultural Immunology. 27 (5): 734-741. https://doi.org/10.1080/09540105.2016.1183598
Wong CY, Yeh KW, Huang JL et al. (2020, Dec). Longitudinal analysis of total serum IgE levels with allergen sensitization and atopic diseases in early childhood. https://doi.org/10.1038/s41598-020-78272-8; PMid:33277617 PMCid:PMC7718260
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Modern Pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
